RBC Capital Reaffirms Their Hold Rating on Universal Health (UHS)
In a report released on February 17, Ben Hendrix from RBC Capital maintained a Hold rating on Universal Health, with a price target of $245.00. The company’s shares closed yesterday at $235.12.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hendrix covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, CVS Health, and Tenet Healthcare. According to TipRanks, Hendrix has an average return of 5.2% and a 51.86% success rate on recommended stocks.
Currently, the analyst consensus on Universal Health is a Moderate Buy with an average price target of $252.20.
Based on Universal Health’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $4.5 billion and a net profit of $372.96 million. In comparison, last year the company earned a revenue of $3.96 billion and had a net profit of $258.71 million
Read More on UHS:
Disclaimer & DisclosureReport an Issue
- Universal Health price target lowered to $262 from $263 at Barclays
- Universal Health price target lowered to $245 from $251 at TD Cowen
- Wells Fargo downgrades Universal Health to Equal Weight, lowers target to $235
- Universal Health downgraded to Equal Weight from Overweight at Wells Fargo
- Universal Health Extends CEO Marc Miller’s Employment Term
